{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:32:25Z","timestamp":1791279145994,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2012.05.025","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T04:02:14Z","timestamp":1337832134000},"page":"1540-1547","source":"Crossref","is-referenced-by-count":32,"title":["Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Christophe","family":"Huret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Miyalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Levacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Amadoudji Zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Bonduelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9hazine","family":"Combadi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Dalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Bellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2012.05.025_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/COH.0b013e32834b879e","article-title":"Update on hepatitis C virus-specific immunity","volume":"6","author":"Ciuffreda","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2012.05.025_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.035956-0","article-title":"The role of neutralizing antibodies in hepatitis C virus infection","volume":"93","author":"Edwards","year":"2012","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.025_bib0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus","volume":"54","author":"Torresi","year":"2011","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.025_bib0020","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.1131929100","article-title":"Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection","volume":"100","author":"Murata","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"10.1016\/j.vaccine.2012.05.025_bib0025","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.025_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2007.01.011","article-title":"Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization","volume":"363","author":"Denis","year":"2007","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.vaccine.2012.05.025_bib0035","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2006.02.051","article-title":"Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV)","volume":"24","author":"Mihailova","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.025_bib0040","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JVI.75.5.2130-2141.2001","article-title":"Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes","volume":"75","author":"Netter","year":"2001","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2012.05.025_bib0045","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.vaccine.2005.11.034","article-title":"DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant","volume":"24","author":"Bellier","year":"2006","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2012.05.025_bib0050","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2009.07.059","article-title":"DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies","volume":"27","author":"Bellier","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.025_bib0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jgm.1307","article-title":"Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development","volume":"11","author":"Desjardins","year":"2009","journal-title":"J Gene Med"},{"issue":"94","key":"10.1016\/j.vaccine.2012.05.025_bib0060","doi-asserted-by":"crossref","first-page":"94ra71","DOI":"10.1126\/scitranslmed.3002330","article-title":"A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques","volume":"3","author":"Garrone","year":"2011","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.025_bib0065","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/mt.2010.222","article-title":"Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses","volume":"19","author":"Torrieri-Dramard","year":"2011","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.025_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.mt.6300054","article-title":"Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines","volume":"15","author":"Dalba","year":"2007","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.025_bib0075","doi-asserted-by":"crossref","first-page":"e11021","DOI":"10.1371\/journal.pone.0011021","article-title":"GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates","volume":"5","author":"Loudon","year":"2010","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.vaccine.2012.05.025_bib0080","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1128\/JVI.05060-11","article-title":"Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen","volume":"85","author":"Winstone","year":"2011","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.025_bib0085","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JVI.02252-07","article-title":"Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance","volume":"82","author":"Yerly","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.025_bib0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.23096","article-title":"Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3","volume":"50","author":"Giugliano","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.025_bib0095","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.052712599","article-title":"Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome","volume":"99","author":"Farci","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.025_bib0100","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/gut.2003.037788","article-title":"Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance","volume":"53","author":"Spada","year":"2004","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.025_bib0105","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1128\/JVI.71.8.6011-6019.1997","article-title":"Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection","volume":"71","author":"Diepolder","year":"1997","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.025_bib0110","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.025_bib0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/505714","article-title":"Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design","volume":"194","author":"Smyk-Pearson","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.025_bib0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.8.3.333","article-title":"Development of hepatitis C virus vaccines: challenges and progress","volume":"8","author":"Stoll-Keller","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.025_bib0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.025_bib0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/157016210793499286","article-title":"An effective HIV vaccine: a combination of humoral and cellular immunity?","volume":"8","author":"Benmira","year":"2010","journal-title":"Curr HIV Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12007293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12007293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T01:50:57Z","timestamp":1594173057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12007293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X12007293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}